Excess mortality and changes in causes of death in Estonia during the Covid-19 pandemic (years 2020 and 2021)

Author:

Pärna Grete1,Lang Katrin1,Kalda Ruth1

Affiliation:

1. University of Tartu

Abstract

Abstract

Background: The aim of this study was to describe the changes in the mortality statistics in Estonia during the period of the Covid-19 pandemic (years 2020 and 2021) in terms of excess mortality and the occurrence of causes of death. Methods: The present study is based on retrospective data obtained from the Estonian Causes of Death Registry and the Statistics Estonia database. Data from the period before the pandemic (01.01.2018–31.12.2019) and the two years of the pandemic (2020 and 2021) were compared. In order to compare mortality in different periods, mortality rates were calculated by gender and age group, and incidence rate ratios were used to determine differences between the periods. Excess mortality was expressed as a percentage based on the incidence rate ratio. Mortality patterns were described according to gender and age group using a change point regression model. To analyze the causes of death, the incidence rate ratios by a given period and primary causes of death groups were found. Results: The study results indicated that the mortality rate in 2020 did not significantly differ from the mortality rate in the reference period. Excess mortality occurred in 2021 and was 15%. Excess mortality in 2021 was mainly caused by increased mortality among men aged 35–54 and ≥50 years and women aged ≥50 years. There have been changes in mortality rate trends that do not exactly coincide with the period of the Covid-19 pandemic. In older age groups, the downward trend of mortality has stopped. Several primary causes of death had significantly higher mortality rates during the pandemic years compared to the reference period. Conclusions: Covid-19 pandemic has had both a direct and an indirect impact on the health and mortality of the Estonian population. Given that Covid-19 continues to spread and comprehensive knowledge of its long-term effects is still limited, continued analysis will be necessary to assess the pandemic's impact on the population's health indicators.

Publisher

Research Square Platform LLC

Reference40 articles.

1. Terviseamet. Eestis diagnoositi esimene Covid-19 haigusjuhtum. [03.05.2023]. (https://www.terviseamet.ee/et/uudised/eestis-diagnoositi-esimene-covid-19haigusjuhtum).

2. Centers for Disease Control and Prevention. CDC Museum COVID-19 Timeline. [03.05.2023]. (https://www.cdc.gov/museum/timeline/covid19.html).

3. „Covid-19 haiguse leviku tõkestamiseks vajalikud liikumisvabaduse ning avalike koosolekute pidamise ja avalike ürituste korraldamise piirangud muutmise seletuskiri. VV korraldus 16.05.2020 nr 172. RT. III 2020, 2.

4. World Health Organization. Achieving 70% Covid-19 immunization coverage by mid-2022. [03.05.2023]. (https://www.who.int/news/item/23-12-2021-achieving-70-covid19- immunization-coverage-by-mid-2022).

5. World Health Organization. WHO/Europe Covid-19 vaccine programme monitor. [03.05.2023]. (https://worldhealthorg.shinyapps.io/EURO_COVID19_vaccine_monitor/).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3